Schizophrenie als Leitkrankheit der Psychiatrie

Roland Vauth; Fritz Hohagen; Winfried Lotz-Rambaldi

doi:10.1055/s-0032-1304920

Psychiatrische Praxis, Table of Contents

Psychiatr Prax 2012; 39(04): 153-156
DOI: 10.1055/s-0032-1304920

Debatte: Pro & Kontra

Schizophrenie als Leitkrankheit der Psychiatrie

Schizophrenia as the Prototypical Psychiatric Disorder

Authors

Roland Vauth
Fritz Hohagen
Winfried Lotz-Rambaldi

Abstract

Full Text

References

Literatur
1 van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature 2010; 468: 203-212
2 Vauth R, Cavelti M, Schieting S et al. Recovery bei schizophrenen Störungen: Ergebnis und Prozess im Fokus moderner Behandlung. Schizophrenie Mitteilungen der gfts 2011; 27: 50-57
3 Vauth R. Psychologische Mechanismen bei der Entwicklung von Depression und ihre Implikationen für psychotherapeutische Ansatzpunkte bei schizophrenen Störungen. neuro aktuell (im Druck)
4 Vauth R. Die umfassende Behandlung schizophrener Störungen als klinische Herausforderung. In: Strauß B, Hohagen F, Caspar F, Hrsg. Lehrbuch Psychotherapie. Teilband 1. Göttingen: Hogrefe; 2007: 611-646
5 Kumari V, Peters ER, Fannon D et al. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia. Biol Psychiatry 2009; 66: 594-602
6 Linden DE et al. How psychotherapy changes the brain – the contribution of functional neuroimaging [Review]. Molecular psychiatry 2006; 11: 528-538
7 Dickerson FB, Lehman AF. Evidence-based psychotherapy for schizophrenia: 2011 update. J Nerv Ment Dis 2011; 199: 520-526
8 Garety PA, Bebbington B, Fowler D et al. Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychological Medicine 2007; 37: 1377-1391
9 Kuipers E, Garety P, Fowler D et al. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Schizophr Bull 2006; 32 (Suppl. 01) 24-S31
10 Rathod S, Phiri P, Kingdon D. Cognitive behavioral therapy for schizophrenia. Psychiatr Clin North Am 2010; 33: 527-536
11 Tarrier N. Cognitive behavior therapy for schizophrenia and psychosis: current status and future directions. Clin Schizophr Relat Psychoses 2010; 4: 176-184
12 Lysaker PH, Tunze C, Yanos PT et al. Relationships between stereotyped beliefs about mental illness, discrimination experiences, and distressed mood over 1 year among persons with schizophrenia enrolled in rehabilitation. Soc Psychiatry Psychiatr Epidemiol 2011; May 21 [Epub ahead of print]
13 Cavelti M, Kvrgic S, Beck EM et al. Self-stigma and its relationship with insight, demoralization, and clinical outcome among people with schizophrenia spectrum disorders. Compr Psychiatry 2011; Sep 26 [Epub ahead of print]
14 Vauth R, Kleim B, Wirtz M et al. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Research 2007; 150: 71-80
15 Beck EM, Cavelti M, Kvrgic S et al. Are we addressing the “right stuff” to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res 2012; 132: 42-49
16 Corrigan PW, Rafacz J, Rusch N. Examining a progressive model of self-stigma and its impact on people with serious mental illness. Psychiatry Res 2001; 189: 339-343
17 Hamann J, Mendel R, Cohen R et al. Psychiatrists’ use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics. Psychiatr Serv 2009; 60: 1107-1112
18 Kreyenbuhl J, Nossel IR, Dixon LB. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophrenia Bulletin 2009; 35: 696-703
19 Miklowitz DJ, Otto MW, Frank E et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. American Journal of Psychiatry 2007; 164: 1340-1347
20 Vauth R. Psychotherapie bei schizophrenen Störungen auf der Grundlage modernen Case Managements. In: Falkai P, Pajonc FG, eds. Langzeittherapie der Schizophrenie. Bremen: Unimed; 2004: 84-97
21 Dixon LB, Dickerson F, Bellack AS et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010; 36: 48-70
22 Vauth R, Corrigan PW, Clauss M et al. Cognitive strategies versus self-management skills as adjunct to vocational rehabilitation. Schizophr Bull 2005; 31: 55-66
23 Salize HJ, McCabe R, Bullenkamp J et al. Cost of treatment of schizophrenia in six European countries. Schizophr Res 2009; 111: 70-77
24 Puschner B, Vauth R, Jacobi F et al. Evidence basis of psychotherapy for schizophrenia patients in Germany. Nervenarzt 2006; 77: 1301-1302, 1304−1309
25 Wobrock T, Pajonk FG, Falkai P. Schizophrenie. Teil 1: Epidemiologie. Ätiopathogenese, Symptomatologie. Fortschr Neurol Psychiat 2004; 72: 98-113
26 Meyer C, Rumpf H-J, Hapke U et al. Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung. Ergebnisse der TACOS-Studie. Nervenarzt 2000; 71: 535-542
27 Lotz-Rambaldi W, Hohagen F. Entwicklung der Psychotherapie im Fachgebiet Psychiatrie und Psychotherapie. Erfolgreiche Einbindung. NeuroTransmitter 2009; 2 (Sonderheft): 6-12
28 Hohagen F. The profile of a psychiatrist. Nervenarzt 2006; 77: 748-750
29 Baxter Jr LR, Schwartz JM, Bergman KS et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689
30 Schwartz JM, Stoessel PW, Baxter Jr LR et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 109-113
31 Zurowski B, Kordon A, Weber-Fahr W et al. Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2012; (in press) DOI:
32 Gesundheitsforschungsrat (GFR) des Bundesministeriums für Bildung und Forschung (BMBF). Roadmap für das Gesundheitsforschungsprogramm der Bundesregierung. 2007
33 Mathers CD, Loncar D. Updated projections of global mortality and burden of disease, 2002−2030: Data sources, methods and results. Public Library of Science Medicine 2006; 3: e442
34 Volk der Erschöpften. DER SPIEGEL 2001; 4: 114-122